- Home
- WNEB vs VYGR Comparison
WNEB vs VYGR Comparison
Compare WNEB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- VYGR
- Stock Information
- Founded
- WNEB 1853
- VYGR 2013
- Country
- WNEB United States
- VYGR United States
- Employees
- WNEB N/A
- VYGR N/A
- Industry
- WNEB Savings Institutions
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- WNEB Finance
- VYGR Health Care
- Exchange
- WNEB Nasdaq
- VYGR Nasdaq
- Market Cap
- WNEB 195.7M
- VYGR 231.9M
- IPO Year
- WNEB N/A
- VYGR 2015
- Fundamental
- Price
- WNEB $11.36
- VYGR $4.54
- Analyst Decision
- WNEB Buy
- VYGR Strong Buy
- Analyst Count
- WNEB 2
- VYGR 8
- Target Price
- WNEB $11.00
- VYGR $16.71
- AVG Volume (30 Days)
- WNEB 48.8K
- VYGR 774.1K
- Earning Date
- WNEB 10-22-2025
- VYGR 11-11-2025
- Dividend Yield
- WNEB 2.47%
- VYGR N/A
- EPS Growth
- WNEB N/A
- VYGR N/A
- EPS
- WNEB 0.59
- VYGR N/A
- Revenue
- WNEB $76,036,000.00
- VYGR $42,580,000.00
- Revenue This Year
- WNEB N/A
- VYGR N/A
- Revenue Next Year
- WNEB $7.36
- VYGR $107.10
- P/E Ratio
- WNEB $19.27
- VYGR N/A
- Revenue Growth
- WNEB 2.15
- VYGR N/A
- 52 Week Low
- WNEB $7.63
- VYGR $2.65
- 52 Week High
- WNEB $12.80
- VYGR $7.44
- Technical
- Relative Strength Index (RSI)
- WNEB 46.21
- VYGR 47.79
- Support Level
- WNEB $10.78
- VYGR $4.72
- Resistance Level
- WNEB $11.44
- VYGR $5.13
- Average True Range (ATR)
- WNEB 0.33
- VYGR 0.35
- MACD
- WNEB -0.01
- VYGR -0.08
- Stochastic Oscillator
- WNEB 43.46
- VYGR 6.31
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.